Moneycontrol PRO
brokerage reports
Jump to
13 Results Found
  • Solara Active: Aurore deal to act as a booster for CRAMS; accumulate Apr 13, 2021 10:38 AM IST

    Solara Active: Aurore deal to act as a booster for CRAMS; accumulate

    The Aurore deal should help Solara in ramping up CRAMS portfolio, diversifying the API product basket and also aiding backward integration

  • Buy Solara Active Pharma Sciences: target of Rs 1730: Sharekhan Apr 13, 2021 10:37 AM IST

    Buy Solara Active Pharma Sciences: target of Rs 1730: Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences has recommended buy rating on the stock with a target price of Rs 1730 in its research report dated April 12, 2021.

  • Buy Solara Active Pharma Sciences; target of Rs 1700: Sharekhan Feb 09, 2021 10:47 PM IST

    Buy Solara Active Pharma Sciences; target of Rs 1700: Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated February 03, 2021.

  • Buy Solara Active Pharma Sciences: target of Rs 1450 : Sharekhan Dec 09, 2020 01:45 PM IST

    Buy Solara Active Pharma Sciences: target of Rs 1450 : Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences recommended buy rating on the stock with a target price of Rs 1450 in its research report dated December 08, 2020.

  • Buy Solara Active Pharma Sciences: target of Rs 1371: Sharekhan Nov 05, 2020 05:00 PM IST

    Buy Solara Active Pharma Sciences: target of Rs 1371: Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences recommended buy rating on the stock with a target price of Rs 1371 in its research report dated October 30, 2020.

  • Buy Solara Active Pharma Sciences; target of Rs 1371: Sharekhan Nov 02, 2020 03:10 PM IST

    Buy Solara Active Pharma Sciences; target of Rs 1371: Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences recommended buy rating on the stock with a target price of Rs 1371 in its research report dated October 30, 2020.

  • Solara Active: Broadening of portfolio to be a re-rating catalyst Nov 02, 2020 09:46 AM IST

    Solara Active: Broadening of portfolio to be a re-rating catalyst

    Solara is on the verge of transforming its business profile. It is looking at utilising cash flows to build project pipeline for CRAMS, investment behind technology platforms and looking for inorganic opportunities

  • Solara Active: Strong execution, but valuations fair Aug 06, 2020 10:12 AM IST

    Solara Active: Strong execution, but valuations fair

    Among the risk factors to track for Solara Active are elevated pledge percentage for promoters which is 51 percent of their shareholdings

  • Weekly Tactical Pick | Solara Active Pharma Sciences Mar 06, 2020 09:26 AM IST

    Weekly Tactical Pick | Solara Active Pharma Sciences

    The stock rides on many tailwinds: business growth opportunity, innovation pipeline and its strong operating performance

  • Solara Active Q2 serves a strong dose, new molecules key trigger Oct 24, 2019 11:43 AM IST

    Solara Active Q2 serves a strong dose, new molecules key trigger

  • Ranitidine controversy: Which Indian pharma companies stand to lose? Sep 30, 2019 02:12 PM IST

    Ranitidine controversy: Which Indian pharma companies stand to lose?

  • This pure API play gains strength on improving product mix Sep 04, 2019 03:40 PM IST

    This pure API play gains strength on improving product mix

  • Ideas for Profit | An API company that combines good growth prospects with reasonable valuations Jul 01, 2019 09:53 AM IST

    Ideas for Profit | An API company that combines good growth prospects with reasonable valuations

Sections
ISO 27001 - BSI Assurance Mark